Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] SK hynix (000660 / SKHY) – Hana | LPDDR Demand · Mobile DRAM Tightness · Earnings Growth / 2026-04-24 Research
  • [Research] Samsung SDI (006400) – iM Securities | ESS Business Pivot · AMPC Benefits · Earnings Visibility / 2026-07-31 Research
  • [Research] Samsung Electronics (005930) – Hana | Memory Earnings Growth · LPDDR Shortage · Uncertainty Relief / 2026-05-04 Research
  • [Research] Hanwha Ocean (042660) – Daishin | Merchant Vessel Margin · FX Impact · US Navy Logistics Synergy / 2026-07-29 Research
  • [Research] Alteogen (196170) – Daishin Securities | Keytruda Qlex Commercial Milestones · RNA Modality Expansion · Platform Re-rating / 2026-08-10 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Dual Growth Engines · 2Q26 OPM Ramp-up · Substrate CapEx Doubling / 2026-05-04 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | AI MLCC Shortage · FC-BGA Margin Expansion · Earnings Direction / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21 Research

[Research] Samsung Electronics (005930) – Mirae Asset Securities | Resilient Memory Spot Pricing · Valuation Attractiveness · Shareholder Returns / 2026-03-09

Posted on 3월 9, 20268월 25, 2026 By ksb220805@gmail.com

Brokerage : Mirae Asset Securities

Analyst : Young-gun Kim

Investment Rating : Buy (Maintained)

Target Price : KRW 275,000 (Maintained)

Core Momentum : Despite near-term share price corrections triggered by US-Iran geopolitical tensions, investment attractiveness is viewed to have heightened based on resilient memory spot pricing, maintained 2026 operating profit forecast of KRW 227T, and potential special shareholder returns from FCF exceeding KRW 60T.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: Buy maintained, Target Price maintained at KRW 275,000 (58.5% upside potential based on the March 9, 2026 closing price of KRW 173,500)
  • Key Valuation Multiples (2026F): P/E 5.6x (12M forward P/E 5.4x), P/B 1.9x (12M forward P/B 1.8x), ROE 39.9%, Dividend Yield 0.8% (assuming a 25% payout ratio and 4Q26 DPS of KRW 8,110 yields 4.7% for common shares and 6.7% for preferred shares in text)
  • Per-Share Metrics (2026F): EPS KRW 31,005 (up significantly from KRW 6,566 in 2025F)
  • Annual Financial Projections:
    • 2024: Revenue KRW 300.87T, Operating Profit KRW 32.73T, Net Profit (Controlling) KRW 33.62T
    • 2025F: Revenue KRW 333.57T, Operating Profit KRW 43.63T, Net Profit (Controlling) KRW 44.28T
    • 2026F: Revenue KRW 561.73T, Operating Profit KRW 226.56T (KRW 227T in text, YoY +419%, OPM 40.3%), Net Profit (Controlling) KRW 208.84T
    • 2027F: Revenue KRW 659.01T, Operating Profit KRW 285.98T (OPM 43.4%), Net Profit (Controlling) KRW 269.90T

🚀 2. [Market Opportunities & Business Outlook]

  • Leading Indicators Amid Geopolitical Turmoil:
    • Following a 19.9% share price decline over 5 trading days post US air strikes on Iran, leading memory indicators remain resilient
    • Spot Pricing: DRAM spot price premiums over March contract prices stand at 290% for DDR5 and 130% for DDR4; post-conflict spot price changes were limited to DDR5 +0.5% and DDR4 -3.1%
  • Demand Dynamics & Safety Stocking:
    • Buyer realignment toward North American AI datacenters lowered consumer IT demand share to the 40% range (historically ~55%), providing insulation against consumer market volatility
    • Lingering supply chain disruption concerns may lead IT hardware OEMs to consider raising safety inventory levels
  • Earnings Forecasts & Shareholder Return Framework:
    • Maintained Projections: 1Q26F Operating Profit projected at KRW 37.4T (+86.2% QoQ) and FY26 Operating Profit at KRW 227T (+419% YoY)
    • Shareholder Returns: As 2026 marks the conclusion of the 3-year shareholder return program, special shareholder returns become available for FCF generated above KRW 60T

📝 Editor’s Comment (Perspective)

The analyst views Samsung Electronics as a market-leading memory manufacturer maintaining robust underlying earnings power (projected 2026 operating profit of KRW 227T), supported by elevated spot price premiums and a demand base anchored by North American AI datacenters, despite near-term geopolitical headwinds. This perspective places primary significance on valuation appeal (12M forward P/E of 5.4x and P/B of 1.8x) underpinned by steady earnings estimates and potential special shareholder returns from FCF exceeding KRW 60T, rather than macro-driven short-term market corrections.

To verify whether this investment thesis continues to materialize, key verification points include whether DRAM spot price premiums and contract price strength hold amid geopolitical uncertainties, whether 1Q (KRW 37.4T) and full-year earnings estimates are realized, and whether special shareholder returns and dividend policies based on cumulative FCF generation are concretely executed. These developments can be monitored through upcoming quarterly earnings releases, official IR presentations, regulatory filings, and periodic financial reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

글 탐색

Previous Post: [Research] KEPCO (015760 / KEP) – Mirae Asset Securities | Nuclear Export Momentum · Tariff Restructuring · Oil & Cost Uncertainties / 2026-03-05
Next Post: [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Server Demand · MLCC Pricing · Dual Upcycle / 2026-03-12

Related Posts

  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | AI MLCC · FC-BGA · ASP Increase / 2026-05-04 Research
  • [Research] Samsung SDI (006400) – IBK Securities | ESS Shipment Expansion · AMPC Benefits · Profit Turnaround / 2026-07-31 Research
  • [Research] Samsung Electronics (005930) – Kyobo | Memory Shortage · HBM4 Volume Ramp · Target Price Upgrade / 2026-05-06 Research
  • [Research] Samsung Electronics (005930) – Daishin Securities | Strategic Pricing · Foundry Breakeven · Shareholder Return / 2026-07-31 Research
  • [Research] LIG D&A (079550) – Shinhan Securities | Structural Export Growth · Order Pipeline · Long-term Demand / 2026-08-07 Research
  • [Research] Samsung SDI (006400) – Mirae Asset | Operating Profit Upgrades · Core Turnaround · Prismatic Competitiveness / 2026-07-31 Research
  • [Research] Samsung Electro-Mechanics (009150) – Eugene Investment & Securities | AI MLCC · FC-BGA · Product Mix Improvement / 2026-05-04 Research
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing Resilience · Earnings Visibility · Valuation Appeal / 2026-04-01 Research
  • [Research] KEPCO (015760 / KEP) – Hana Securities | Industrial Tariff Cut Pressure · Subsidiary Cost Risks · Nuclear Output Normalization / 2026-02-27 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | Plant 5 Ramp-up · Resolution of Labor Risk · Annual Guidance Delivery / 2026-06-29 Research
  • [Research] SK hynix (000660 / SKHY) – Meritz | ADR Listing · Valuation Discount · Re-rating / 2026-04-23 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · PHLX Inclusion · Valuation Re-rating / 2026-06-01 Research
  • [Research] ABL Bio (298380) – Yuanta Securities | Givastomig Efficacy · Bispecific ADC · Platform Valuation / 2026-01-29 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme